Geriatric Medicines Market Market USD 1,157.34 billion by 2026
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
“According to Polaris Market Research report, Geriatric Medicines Market is witnessing major innovations & transformations and is anticipated to reach USD 1,157.34 billion by 2026 during the forecast period 2018 to 2026. The global Geriatric Medicines Market report sheds light on the key dynamics of the global market, analyzing the data on a historical basis and forecasted data till the year 2026 The market analysis covered in the report includes data in terms of value USD 1,157.34 Billion.The market overview section of the report covers the global industry overview, microeconomic and macroeconomic outlook, and forecasted factors. The market dynamics section of this report includes major drivers, restraints, trends, and opportunities emerging in the market.
Geriatric Medicines Market Report Scope: The global Geriatric Medicines Market is segmented based on therapeutic category, therapeutic condition, and geography. The motive of the research report is to define market dynamics of different countries & segments in the recent time and to forecast the values for the coming years. The report is specifically designed to incorporate quantitative and qualitative aspects of the market within each country and region involved in the study. The report caters the extensive information regarding the driving factors & hurdles that will define the future outlook for the market. Additionally, the report also incorporates prevailing and emerging opportunities for
-2-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
stakeholders to invest along with the in-depth detailed analysis of product/services offerings of prominent players shaping the overall development of the market. By Therapeutic Category
• • • • • • • •
Analgesics Antihypertensives Statins Antidiabetics Proton Pump Inhibitor Anticoagulant Antipsychotic Antidepressant
Therapeutic Condition • • • • • •
Cardiovascular Arthritis Neurological Cancer Osteoporosis Respiratory
By Region Type • • • • •
North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) Asia Pacific (Japan, China, India, Malaysia, Indonesia, South Korea) Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)
COVID-19 Impact Analysis for Geriatric Medicines Market COVID-19 is an ongoing public health emergency that has impacted almost all industries globally, and its longterm effects are expected to influence the target industry growth over the forecast period. Our ongoing research features the COVID-19 impact analysis section as a key part of the report to uncover the major issues and potential paths forward. In this report, the insights provided in terms of changes in consumer behavior and purchasing patterns, dynamics of current market forces, re-routing of the supply chain, and the interventions of governments. The latest study incorporates analysis, estimations, insights, and forecasts, considering the COVID-19 impact on the market. Gain access to our latest research report that includes in-depth analysis of the COVID-19 pandemic impacting the the Geriatric Medicines Market in different regions and how leading players are forming strategies to mitigate the adverse effect of the pandemic and take benefit of emerging opportunities : Browse Detailed Research Report On Geriatric Medicines Market Analysis: https://www.polarismarketresearch.com/industry-analysis/geriatric-medicines-market
Regional Outlook Among regional markets, the region emerged as the promising regional market with its higher revenue share contribution. The growth in this regional market is primarily attributed to the ongoing technological advancements in the industry, increasing economic stability, huge government investments, and growing awareness related to the benefits of the product/service. Competitive Landscape
-3-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
The report offers a complete industry analysis while featuring the competitive landscape that includes company financials, product portfolios, major breakthroughs, and upcoming projects. The report includes a detailed view of the global market, along with changing scenarios, trends, regional segmentation, regional landscape, major investments, and details of historical, present, and projected revenues. According to Polaris Market Research, the key players with a noteworthy dominance in the Geriatric Medicines Market include GlaxoSmithKline Plc, BoehringerIngelheim GmbH, Novartis AG, Bristol-Myers Squibb Company, Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories Inc., AstraZeneca plc, Merck & Company Inc., and Sanofi S.A. among others. Request for sample: https://www.polarismarketresearch.com/industry-analysis/geriatric-medicinesmarket/request-for-sample
Table of Contents 1. Overview and Scope 1.1. Research goal & scope 1.2. Research assumptions 1.3. Research Methodology 1.3.1.Primary data sources 1.3.2.Secondary data sources 1.4. Key take-aways 1.5. Stakeholders 2. Executive Summary 2.1. Market Definition 2.2. Market Segmentation 3. Geriatric Medicines Market Insights 3.1. Geriatric Medicines – Industry snapshot 3.2. Geriatric Medicines - Ecosystem analysis 3.3. Geriatric Medicines Market dynamics 3.3.1.Geriatric Medicines – Market Forces 3.3.1.1. Geriatric Medicines Market driver analysis 3.3.1.2. Geriatric Medicines Market restraint/challenges analysis 3.3.1.3. Geriatric Medicines Market opportunity analysis 3.4. Industry analysis - Porter's five force 3.4.1.Bargaining power of supplier 3.4.2.Bargaining power of buyer 3.4.3.Threat of substitute 3.4.4.Threat of new entrant 3.4.5.Degree of competition 3.5. Geriatric Medicines Market PEST analysis, 2017 3.5.1.Geriatric Medicines Industry trends 3.5.2.Competitive Ranking Analysis 4. Geriatric Medicines Market Size and Forecast by Therapeutic Category 4.1. Key findings 4.2. Analgesics 4.2.1.Global market estimates and forecasts, 2017 – 2026 -4-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
4.3. Antihypertensives 4.3.1.Global market estimates and forecasts, 2017 – 2026 4.4. Statins 4.4.1.Global market estimates and forecasts, 2017 – 2026 4.5. Antidiabetics 4.5.1.Global market estimates and forecasts, 2017 – 2026 4.6. Proton Pump Inhibitor 4.6.1.Global market estimates and forecasts, 2017 – 2026 4.7. Anticoagulant 4.7.1.Global market estimates and forecasts, 2017 – 2026 4.8. Antipsychotic 4.8.1.Global market estimates and forecasts, 2017 – 2026 4.9. Antidepressant 4.9.1.Global market estimates and forecasts, 2017 – 2026 5. Geriatric Medicines Market Size and Forecast by Therapeutic Condition 5.1. Key findings 5.2. Cardiovascular 5.2.1.Global market estimates and forecasts, 2017 - 2026 5.3. Arthritis 5.3.1.Global market estimates and forecasts, 2017 – 2026 5.4. Neurological 5.4.1.Global market estimates and forecasts, 2017 – 2026 5.5. Cancer 5.5.1.Global market estimates and forecasts, 2017 - 2026 5.6. Osteoporosis 5.6.1.Global market estimates and forecasts, 2017 – 2026 5.7. Respiratory 5.7.1.Global market estimates and forecasts, 2017 – 2026 6. Geriatric Medicines Market Size and Forecast by Regions 6.1. Key findings 6.2. North America 6.2.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.2.3.U.S. 6.2.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.2.4.Canada 6.2.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.2.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3. Europe 6.3.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.3.Germany 6.3.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.4.UK 6.3.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.3.5.France 6.3.5.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.5.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 -5-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
6.3.6.Italy 6.3.6.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.3.6.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4. Asia Pacific 6.4.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.3.China 6.4.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.4.India 6.4.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.5.Japan 6.4.5.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.5.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.4.6.Australia 6.4.6.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.4.6.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5. Latin America 6.5.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5.3.Brazil 6.5.3.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.3.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.5.4.Mexico 6.5.4.1. Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.5.4.2. Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 6.6. Middle East & Africa 6.6.1.Geriatric Medicines Market by Therapeutic Category, 2017 - 2026 6.6.2.Geriatric Medicines Market by Therapeutic Condition, 2017 - 2026 7. Company Profiles 7.1. GlaxoSmithKline Plc 7.1.1.Overview 7.1.2.Financials 7.1.3.Product Benchmarking 7.1.4.Recent Developments 7.2. BoehringerIngelheim GmbH 7.2.1.Overview 7.2.2.Financials 7.2.3.Product Benchmarking 7.2.4.Recent Developments 7.3. Novartis AG 7.3.1.Overview 7.3.2.Financials 7.3.3.Product Benchmarking 7.3.4.Recent Developments 7.4. Bristol-Myers Squibb Company 7.4.1.Overview 7.4.2.Financials 7.4.3.Product Benchmarking 7.4.4.Recent Developments -6-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
7.5. Pfizer, Inc. 7.5.1.Overview 7.5.2.Financials 7.5.3.Product Benchmarking 7.5.4.Recent Developments 7.6. Eli Lilly and Company 7.6.1.Overview 7.6.2.Financials 7.6.3.Product Benchmarking 7.6.4.Recent Developments 7.7. Abbott Laboratories Inc. 7.7.1.Overview 7.7.2.Financials 7.7.3.Product Benchmarking 7.8. AstraZeneca plc 7.8.1.Overview 7.8.2.Financials 7.8.3.Product Benchmarking 7.8.4.Recent Developments 7.9. Merck & Company Inc. 7.9.1.Overview 7.9.2.Financials 7.9.3.Product Benchmarking 7.9.4.Recent Developments 7.10. Sanofi S.A. 7.10.1. Overview 7.10.2. Financials 7.10.3. Product Benchmarking 7.10.4. Recent Developments Access Press Release on Geriatric Medicines Market: https://www.polarismarketresearch.com/pressreleases/geriatric-medicines-market
About Polaris Market Research Polaris Market Research is a global market research and consulting company. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors, and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments, and the latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities. Adept with a highly competent, experienced, and extremely qualified team of experts comprising SMEs, analysts, and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. E mail Id: sales@polarismarketresearch.com
-7-
Geriatric Medicines Market Size Worth USD 1,157.34 billion by 2026
Web: www.polarismarketresearch.com Official Blog: http://polarismarketresearch.blogspot.com
-8-